“Genetic Assessment and Surveillance of Antibiotic Resistance Study”
Step up with GASAR. Contribute to a repository that's reshaping India's approach to the threat of antimicrobial resistance.
The GASAR Study aims to address the growing concern of antibiotic resistance in India, among critical priority gram-negative pathogens identified by the World Health Organization (WHO). This initiative involves collecting and analysing the multi drug resistant gram-negative bacterial isolates from various hospitals across different geographical locations of India, with the primary goal of providing comprehensive information about the resistant genes present within these pathogens. To become India's largest surveillance program along the likes of SENTRY and ATLAS
Express Interest
Antimicrobial Resistance directly lead to killing at least 1.27 million people worldwide and associated with nearly 5 million deaths in 2019: THE LANCET
In India in 2019, there were 297,000 deaths attributable to AMR and 1 Million deaths associated with AMR: IHME
Recognizing that antimicrobial resistance can vary significantly from region to region, focusing on resistance data from Indian hospitals across regional geographies, GASAR study is expected to help the clinicians tailor their efforts to the specific challenges faced in the region.
Study approach goes beyond traditional resistance data collection. It delves into the genetic characteristics of pathogens. This means microbiologists will not only identify which antibiotics are effective or not but also gain insights into the genetic mechanisms driving resistance. This level of detail enables a more nuanced understanding of resistance patterns and paves the way for more targeted treatment strategies..